Intriguingly, HRG dramatically decreased NK cell surface PD‐1 expression, which was associated with augmented cytotoxic activity against K562 cells, a chronic myelocytic leukemia cell line. This evidence concerns the gene PDCD1 and chronic myelogenous leukemia, BCR-ABL1 positive.